Alan M. Aron
Icahn School of Medicine at Mount Sinai
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alan M. Aron.
The New England Journal of Medicine | 1992
Peter M. Schantz; Anne C. Moore; Jose Munoz; Barry J. Hartman; John A. Schaefer; Alan M. Aron; Deborah Persaud; Elsa Sarti; Marianna Wilson; Ana Flisser
BACKGROUND AND METHODS From June 1990 through July 1991, intracerebral infection with the larval stage of the pork tapeworm Taenia solium was diagnosed in four unrelated persons in an Orthodox Jewish community in New York City. None of the patients had eaten pork, and only one had traveled to a country in which T. solium infection was endemic. We investigated this outbreak, screened serum samples from family members and household contacts for antibodies to cysticercosis, and examined stool specimens from household employees for eggs of taenia species. RESULTS The four patients had recurrent seizures and brain lesions that were radiologically consistent with the presence of cysticerci. The diagnosis was confirmed in two patients by a brain biopsy, and in two by immunoblot assays for cysticercus antibodies. Of 17 immediate family members screened serologically, 7 from two families had cysticercus antibodies. Magnetic resonance imaging of the brain showed cystic lesions in two of the seropositive family members, one of whom had had a seizure. Examinations of six domestic employees from all four households revealed an active infection with taenia species in one and a positive serologic test in another. Since these women had recently emigrated from Latin American countries where T. solium infection is endemic, they were the most likely sources of infection in the members of these households. CONCLUSIONS A diagnosis of neurocysticercosis should be considered in patients with seizures and radiologic evidence of cystic brain lesions, even in those who do not eat pork and who have not traveled to a country in which T. solium infection is endemic. Recent emigrants from countries in which T. solium infection is endemic should be screened for tapeworm infection in their stools before they are employed as housekeepers or food handlers.
Pediatric Neurology | 2009
Patricia K. Duffner; Michele Caggana; Joseph J. Orsini; David A. Wenger; Marc C. Patterson; Carl J. Crosley; Joanne Kurtzberg; Georgianne L. Arnold; Maria L. Escolar; Darius J. Adams; Mary R. Andriola; Alan M. Aron; Emma Ciafaloni; Alexandra Djukic; Richard W. Erbe; Patricia Galvin-Parton; Laura Helton; Edwin H. Kolodny; Barry E. Kosofsky; David Kronn; Jennifer M. Kwon; Paul A. Levy; Jill Miller-Horn; Thomas P. Naidich; Joan E. Pellegrino; James M. Provenzale; Stanley J. Rothman; Melissa P. Wasserstein
Krabbe disease is a rare inherited neurologic disorder affecting the central and peripheral nervous systems. The disease has four phenotypes: early infantile, later onset, adolescent, and adult. The only known treatment is hematopoietic stem cell transplantation, which is, in the early infantile form of the disease, most beneficial if performed before onset of clinical symptoms. In August 2006, New York State began screening all newborns for Krabbe disease. A rapid and accurate technique for assessing galactocerebrosidase activity and performing DNA mutation analysis had been developed. Interpreting these results was limited, however, because neither enzyme activity nor genetic mutation reliably predicts phenotype. A series of initiatives were therefore developed by a multidisciplinary group of neurologists, geneticists, metabolic pediatricians, neurodevelopmental pediatricians, and transplant physicians (the Krabbe Consortium of New York State) to enhance the effectiveness of the newborn screening program. A standardized clinical evaluation protocol was designed based on the available literature, criteria for transplantation for the early infantile phenotype were formulated, a clinical database and registry was developed, and a study of developmental and functional outcomes was instituted. This multidisciplinary standardized approach to evaluating infants who have positive results on newborn screening may serve as a model for other states as they begin the process of screening for Krabbe disease and other lysosomal storage disorders.
Neurology | 2006
Margaret M. McGovern; Alan M. Aron; Scott E. Brodie; Robert J. Desnick; Melissa P. Wasserstein
Objective: To describe the disease course and natural history of Type A Niemann-Pick disease (NPD). Methods: Ten patients with NPD-A (six male, four female; age range at entry: 3 to 6 months) were serially evaluated including clinical neurologic, ophthalmologic, and physical examinations, and assessment of development. Laboratory analyses, abdominal and brain ultrasounds, and chest radiographs also were obtained and information on intercurrent illnesses and cause of mortality was collected. Results: All affected infants had a normal neonatal course and early development. The first symptom detected in all patients was hepatosplenomegaly. Developmental age did not progress beyond 10 months for adaptive behavior, 12 months for expressive language, 9 months for gross motor skills, and 10 months for fine motor skills. Non-neurologic symptoms included frequent vomiting, failure to thrive, respiratory infections, irritability, and sleep disturbance. Neurologic examination at the time of presentation was normal in most patients. Later neurologic examinations revealed progressive hypotonia with loss of the deep tendon reflexes. All patients had cherry red spots by 12 months. The median time from diagnosis to death was 21 months. The cause of death was respiratory failure in nine patients and complications from bleeding in the tenth. Conclusions: The clinical course in Type A Niemann-Pick disease is similar among affected patients and is characterized by a relentless neurodegenerative course that leads to death, usually within 3 years.
Genetics in Medicine | 2016
Melissa P. Wasserstein; Mary R. Andriola; Georgianne L. Arnold; Alan M. Aron; Patricia K. Duffner; Richard W. Erbe; Maria L. Escolar; Lissette Estrella; Patricia Galvin-Parton; Alejandro Iglesias; Denise M. Kay; David Kronn; Joanne Kurtzberg; Jennifer M. Kwon; Thomas J. Langan; Paul A. Levy; Thomas P. Naidich; Joseph J. Orsini; Joan E. Pellegrino; James M. Provenzale; David A. Wenger; Michele Caggana
Background:Early infantile Krabbe disease is rapidly fatal, but hematopoietic stem cell transplantation (HSCT) may improve outcomes if performed soon after birth. New York State began screening all newborns for Krabbe disease in 2006.Methods:Infants with abnormal newborn screen results for Krabbe disease were referred to specialty-care centers. Newborns found to be at high risk for Krabbe disease underwent a neurodiagnostic battery to determine the need for emergent HSCT.Results:Almost 2 million infants were screened. Five infants were diagnosed with early infantile Krabbe disease. Three died, two from HSCT-related complications and one from untreated disease. Two children who received HSCT have moderate to severe developmental delays. Forty-six currently asymptomatic children are considered to be at moderate or high risk for development of later-onset Krabbe disease.Conclusions:These results show significant HSCT-associated morbidity and mortality in early infantile Krabbe disease and raise questions about its efficacy when performed in newborns diagnosed through newborn screening. The unanticipated identification of “at risk” children introduces unique ethical and medicolegal issues. New York’s experience raises questions about the risks, benefits, and practicality of screening newborns for Krabbe disease. It is imperative that objective assessments be made on an ongoing basis as additional states begin screening for this disorder.Genet Med 18 12, 1235–1243.
Journal of Child Neurology | 2005
Alan M. Aron
Two patients with Sydenhams chorea were evaluated with positron emission tomographic (PET) scans in the active phase of the disease. One patient had repeat scanning in the recovery phase. PET scans showed hypermetabolic changes of the caudate nuclei and putamen in the active phase of Sydenhams chorea. The scan reverted to normal in the recovery phase. These changes can afford a basis for comparing concurrent serum antibody studies in the acute and recovery phases of Sydenhams chorea. (J Child Neurol 2005;20:832—833).
Pediatric Neurology | 1991
Steven L. Kugler; Asher Barzilai; David S. Hodes; Aryeh Stollman; Chun K. Kim; Alexander C. Hyatt; Alan M. Aron
An acute hemiplegia secondary to a large cerebral infarct is described in a 16-month-old infant with congenitally-acquired human immunodeficiency virus infection. Serial imaging studies during the next year documented improvement in his hemiplegia and a static underlying human immunodeficiency virus encephalopathy. Acquired immunodeficiency syndrome should be included in the differential diagnosis of children with acute hemiplegia.
Clinical Neurology and Neurosurgery | 1989
Eliezer Lahat; Charles Lanzieri; Sibylle Wallace; Alan M. Aron
The clinical syndrome of pure motor hemiparesis occurs with lacunar lesions in the internal capsule or in the basis pontis in hypertensive adults. It has been described in three patients with brain stem tumors of which two were children. A 3 1/2 years old boy with a brain stem tumor which presented as pure motor hemiparesis is described.
The Journal of Pediatrics | 2006
Melissa P. Wasserstein; Alan M. Aron; Scott E. Brodie; Calogera M. Simonaro; Robert J. Desnick; Margaret M. McGovern
Ophthalmology | 2004
Margaret M. McGovern; Melissa P. Wasserstein; Alan M. Aron; Robert J. Desnick; Edward H. Schuchman; Scott E. Brodie
The Journal of Pediatrics | 1973
Nicholas G. Beratis; Alan M. Aron; Kurt Hirschhorn